F Fuzkk Atlas of Asia, the Middle East, Canada, Australia and Africa
#239Extended selection 101–300

Alpha-9 Theranostics

Canada · Canada

Oncology / ADC / high-potencyRadiopharmaceuticals

Manufacturing profile

Oncology / ADC / high-potency
Radiopharmaceuticals

Country: Canada

Macro-region: Canada

Selection basis

The company is placed in positions 101–300 as a manufacturer, biotech, specialty-pharma, generics or CDMO company with practical relevance to the existing FUZKK catalog.

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.

Representative manufacturing and QC chain

  1. 1Contained dispensing and high-potency handling
  2. 2Chemical synthesis or biologic upstream
  3. 3Purification and formulation
  4. 4HPLC/LC-MS/CE and potency analytics
  5. 5Controlled fill-finish, cleaning and release evidence
  6. 6Radionuclide production or isotope sourcing
  7. 7Shielded synthesis and hot-cell operations
  8. 8Sterile filtration and aseptic dispensing
  9. 9Activity, identity and radionuclidic/radiochemical purity

Relevant FUZKK packages

ADC / Conjugated Biologics QC SuiteGlobal API & Biosimilars QC SuiteRPH: combined radiopharmaceutical QC packageRadioligand & Theranostics Expansion QC Suite

Product/API utilities

ADC Aggregation MonitorADC Drug Antibody Ratio AnalyzerADC Free Payload QuantifierADC Linker Stability ProfilerADCRelease Readiness CheckerRadionuclidic Purity CheckerCold Chain Shipping Temperature And MKT Quality Checker

Lumex — instrumental QC

System Suitability Parameters Checker

LabEx — laboratory QC

Assay & Impurity HPLC Quality CheckerLC-MS Confirmation Quality CheckerSterility Test Membrane Filtration Quality CheckerBacterial Endotoxins LAL Quality CheckerParticle Count Injection USP <788> Quality Checker

Medical Devices — equipment and software lifecycle

Supplier Evaluation CheckerCalibration Status CheckerProcess Validation CheckerChange Control Impact CheckerRequirement Traceability CheckerData Integrity Security Checker

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.

Methodology